1. High Mobility Group Box-1 (HMGB1): A Potential Target in Therapeutics
   Eyaldeva C. Vijayakumar et al, 2019, CDT CrossRef
2. Involvement of HMGB1 in vemurafenib resistance in thyroid cancer cells harboring BRAF (V600E) mutation by regulating excessive autophagy.
   Lin Run et al, 2021, Endocrine CrossRef
3. Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation
   Milad Ashrafizadeh et al, 2024, Cancer Metastasis Rev CrossRef